16 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DADE BEHRING HEPARIN CALIBRATOR AND CONTROLS

FDA 510(k)
FDA Class 2 ·Hematology

ACETABULAR PLATES

FDA 510(k)
FDA Class 2 ·Orthopedic

DRYSTAR, MODEL 4500M

FDA 510(k)
FDA Class 2 ·Radiology

DEXCOM G7 CONTINUOUS GLUCOSE MONITORING SYSTEM

FDA Adverse Event
Malfunction ·DEXCOM, INC.·Product code QBJ·February 21, 2025

PERCLOSE PROGLIDE¿

FDA Adverse Event
Injury ·ABBOTT VASCULAR INC.·Product code MGB·December 9, 2024

4 FR S/L GROSHONG NXT CLEARVUE BASIC KIT W/MICROINTRODUCER

FDA Adverse Event
Malfunction ·C. R. BARD INC. (BASD)·Product code LJS·March 7, 2013

9800

FDA Adverse Event
Malfunction ·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·March 25, 2011

SELUTE PICOTIP LEAD

FDA Adverse Event
Injury ·CARDIAC PACEMAKERS, INC·Product code DTB·May 8, 2008

COCR FEMORAL HEAD

FDA Adverse Event
Injury ·ZIMMER MANUFACTURING B.V.·Product code LPH·November 6, 2019

XLPE LINER ELEVATED RIM

FDA Adverse Event
Injury ·ZIMMER BIOMET, INC.·Product code LPH·November 6, 2019

TRILOGY SHELL

FDA Adverse Event
Injury ·ZIMMER MANUFACTURING B.V.·Product code LPH·November 6, 2019

STARCLOSE SE

FDA Adverse Event
Injury ·ABBOTT VASCULAR INC.·Product code MGB·September 18, 2024

PROMUS EVEROLIMUS ELUTING CORONARY STENT SYSTEM

FDA Adverse Event
Malfunction ·AV-TEMECULA-CT·Product code NIQ·February 4, 2011

StarClose SE Vascular Closure System, Part No. 14679-01, 14679-02. The UDI is 08717648079467. The GMDN is 47411.

FDA Enforcement
Class II ·Terminated·Abbott Vascular·February 22, 2017

Daig Livewire Steerable, Product Number 401915; REPROCESSED ELECTROPHYSIOLOGY CATHETER

FDA Enforcement
Class II ·Ongoing·Stryker Sustainability Solutions·May 20, 2026

Fortify Assura, Sterile EO, Model #/ Part #: CD1257-40/100042322, 100059623; CD1257-40Q/100042341, 100059535; CD1259-40/100041914, 100042338, 100059536, 100059646, 100081567; CD1259-40Q/100041931, 100042339, 100059537, 100059620, 100059626, 100078685; CD1263-40/100042948; CD1263-40Q/100042949; CD1357-40C/100080365, 100080377, 100083441; CD1357-40Q/100080389, 100080390, 100083388; CD1359-40/100078740, 100083267, 100096839; CD1359-40C/100078500, 100078969, 100079372, 100079373, 100083442, 100083443, 100117545; CD1359-40Q/100078804, 100079155, 100079413, 100083445, 100096884; CD1359-40QC/100078603, 100079145, 100079146, 100079239, 100083405, 100083444, 100117632, 100127000, 100127065; CD1363-40C/100080349; CD1363-40Q/100080317; CD1391-40C/100080756; CD1391-40QC/100080783; CD2257-40/100042337, 100059839; CD2257-40Q/100042342, 100059842; CD2259-40/100041893, 100042308, 100059794, 100059907, 100082567; CD2259-40Q/100041894, 100042309, 100059845, 100059873, 100078610; CD2263-40/100042950; CD2263-40Q/100043201; CD2357-40C/100080404, 100080413, 100083490; CD2357-40Q/100080319, 100080412, 100083492; CD2359-40/100078750, 100083466; CD2359-40C/100078651, 100079201, 100079240, 100079442, 100083501, 100083502, 100117546; CD2359-40Q/100078841, 100079109, 100083472; CD2359-40QC/100078652, 100079156, 100079157, 100079337, 100083407, 100083465, 100117580, 100127092, 100127103; CD2363-40C/100080416; CD2363-40Q/100080407; CD2391-40C/100080784; CD2391-40QC/100080744

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 4, 2018